Return On Assets in % of Larimar Therapeutics, Inc. from Q1 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Larimar Therapeutics, Inc. quarterly and annual Return On Assets history and change rate from Q1 2015 to Q3 2025.
  • Larimar Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -75%, a 130% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Return On Assets for 2024 was -36%, a 3.8% decline from 2023.
  • Larimar Therapeutics, Inc. annual Return On Assets for 2023 was -34%, a 4.5% increase from 2022.
  • Larimar Therapeutics, Inc. annual Return On Assets for 2022 was -36%, a 40% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Larimar Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -75% -42% -130% 01 Jul 2025 30 Sep 2025
Q2 2025 -54% -20% -59% 01 Apr 2025 30 Jun 2025
Q1 2025 -46% -14% -43% 01 Jan 2025 31 Mar 2025
Q4 2024 -36% -1.3% -3.8% 01 Oct 2024 31 Dec 2024
Q3 2024 -32% -3.4% -12% 01 Jul 2024 30 Sep 2024
Q2 2024 -34% -7.4% -28% 01 Apr 2024 30 Jun 2024
Q1 2024 -32% -2.4% -7.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -34% +1.6% +4.5% 01 Oct 2023 31 Dec 2023
Q3 2023 -29% +12% +29% 01 Jul 2023 30 Sep 2023
Q2 2023 -27% +31% +54% 01 Apr 2023 30 Jun 2023
Q1 2023 -30% +30% +50% 01 Jan 2023 31 Mar 2023
Q4 2022 -36% +24% +40% 01 Oct 2022 31 Dec 2022
Q3 2022 -41% +20% +33% 01 Jul 2022 30 Sep 2022
Q2 2022 -58% -7.8% -16% 01 Apr 2022 30 Jun 2022
Q1 2022 -60% -16% -36% 01 Jan 2022 31 Mar 2022
Q4 2021 -59% -19% -46% 01 Oct 2021 31 Dec 2021
Q3 2021 -61% -16% -36% 01 Jul 2021 30 Sep 2021
Q2 2021 -50% -4.5% -9.9% 01 Apr 2021 30 Jun 2021
Q1 2021 -44% -5.7% -15% 01 Jan 2021 31 Mar 2021
Q4 2020 -41% -9.5% -31% 01 Oct 2020 31 Dec 2020
Q3 2020 -45% -15% -51% 01 Jul 2020 30 Sep 2020
Q2 2020 -46% -13% -40% 01 Apr 2020 30 Jun 2020
Q1 2020 -38% +7.1% +16% 01 Jan 2020 31 Mar 2020
Q4 2019 -31% +26% +46% 01 Oct 2019 31 Dec 2019
Q3 2019 -30% +29% +50% 01 Jul 2019 30 Sep 2019
Q2 2019 -33% +29% +47% 01 Apr 2019 30 Jun 2019
Q1 2019 -45% +9.3% +17% 01 Jan 2019 31 Mar 2019
Q4 2018 -58% -9.2% -19% 01 Oct 2018 31 Dec 2018
Q3 2018 -58% -15% -35% 01 Jul 2018 30 Sep 2018
Q2 2018 -61% -20% -50% 01 Apr 2018 30 Jun 2018
Q1 2018 -55% -16% -41% 01 Jan 2018 31 Mar 2018
Q4 2017 -48% -9.8% -25% 01 Oct 2017 31 Dec 2017
Q3 2017 -43% -0.3% -0.7% 01 Jul 2017 30 Sep 2017
Q2 2017 -41% +1.1% +2.5% 01 Apr 2017 30 Jun 2017
Q1 2017 -39% +1% +2.6% 01 Jan 2017 31 Mar 2017
Q4 2016 -39% -3.9% -11% 01 Oct 2016 31 Dec 2016
Q3 2016 -43% -11% -36% 01 Jul 2016 30 Sep 2016
Q2 2016 -42% -9.8% -31% 01 Apr 2016 30 Jun 2016
Q1 2016 -40% -10% -36% 01 Jan 2016 31 Mar 2016
Q4 2015 -35% 01 Oct 2015 31 Dec 2015
Q3 2015 -32% 01 Jul 2015 30 Sep 2015
Q2 2015 -32% 01 Apr 2015 30 Jun 2015
Q1 2015 -29% 01 Jan 2015 31 Mar 2015

Larimar Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -36% -1.3% -3.8% 01 Jan 2024 31 Dec 2024
2023 -34% +1.6% +4.5% 01 Jan 2023 31 Dec 2023
2022 -36% +24% +40% 01 Jan 2022 31 Dec 2022
2021 -59% -19% -46% 01 Jan 2021 31 Dec 2021
2020 -41% -11% -37% 01 Jan 2020 31 Dec 2020
2019 -30% +28% +49% 01 Jan 2019 31 Dec 2019
2018 -58% -9.2% -19% 01 Jan 2018 31 Dec 2018
2017 -48% -9.8% -25% 01 Jan 2017 31 Dec 2017
2016 -39% -3.9% -11% 01 Jan 2016 31 Dec 2016
2015 -35% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.